Sutro Biopharma, Inc. (STRO)
12.23
+0.48
(+4.09%)
USD |
NASDAQ |
Jan 09, 16:00
12.31
+0.08
(+0.65%)
After-Hours: 20:00
Sutro Biopharma Shareholders Equity (Quarterly): -87.27M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| GT Biopharma, Inc. | 3.00M |
| Daré Bioscience, Inc. | 2.858M |
| Syndax Pharmaceuticals, Inc. | 115.43M |
| Crinetics Pharmaceuticals, Inc. | 1.072B |
| NovaBay Pharmaceuticals, Inc. | 1.634M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 209.66M |
| Total Liabilities (Quarterly) | 296.93M |
| Debt to Equity Ratio | -2.607 |
| Current Ratio | 2.533 |
| Net Debt Paydown Yield | -10.04% |